BJERKHOLT ERIC
SEC CIK 1197350 · EDGAR
BoughtSold
Most active insiders at MIRM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Peetz Christopher | CEO, Dir | — | $16.29M |
| 2 | GREY MICHAEL G | Dir | — | $11.10M |
| 3 | Heron Patrick J | Dir | $9.00M | — |
| 4 | Howe Jolanda | SVP, Gbl Ctrl | — | $5.55M |
| 5 | BJERKHOLT ERIC | CFO | — | $3.56M |
| 6 | Radovich Peter | Pres AND COO | — | $2.32M |
| 7 | Ramasastry Saira | Dir | — | $1.92M |
| 8 | Quan Joanne | Chief MEDICAL Off | — | $1.46M |
| 9 | Cardon Lon | Dir | — | — |
| 10 | Fischer Laurent | Dir | — | — |
Transactions 38
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-15 16:10 | 2026-09-11 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | M - OptEx | — | +18.3K | 54.7K | +50% | — |
| D | 2026-09-15 16:10 | 2026-09-14 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | S - Sale+OE | $98.37 | -9,943 | 44.7K | -18% | -$978.1K |
| T | 2026-08-12 17:14 | 2026-08-11 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | S - Sale | $99.90 | -6,001 | 36.4K | -14% | -$599.5K |
| MT | 2026-07-08 17:07 | 2026-07-06 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | S - Sale | $122.25 | -5,000 | 42.2K | -11% | -$611.3K |
| 2026-06-11 21:17 | 2026-06-09 | CERS | CERUS CORP | BJERKHOLT ERIC | Dir | S - Sale | $2.60 | -20.5K | 261.7K | -7% | -$53.2K | |
| DMT | 2026-06-09 21:21 | 2026-06-08 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | S - Sale+OE | $93.82 | -5,000 | 44.8K | -10% | -$469.1K |
| DT | 2026-06-09 21:21 | 2026-06-09 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | M - OptEx | $26.49 | +2,393 | 47.2K | +5% | +$63.4K |
| 2026-06-02 19:54 | 2026-06-02 | CERS | CERUS CORP | BJERKHOLT ERIC | Dir | A - Grant | $0.00 | +60.0K | 282.1K | +27% | $0 | |
| D | 2026-03-17 | 2026-03-16 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | S - Sale+OE | $91.98 | -7,287 | 49.8K | -13% | -$670.3K |
| D | 2026-03-17 | 2026-03-15 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | M - OptEx | — | +13.3K | 57.1K | +30% | — |
| D | 2026-01-27 | 2026-01-23 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | M - OptEx | — | +2,667 | 44.8K | +6% | — |
| D | 2026-01-27 | 2026-01-26 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | S - Sale+OE | $96.19 | -1,053 | 43.7K | -2% | -$101.3K |
| D | 2026-01-23 | 2026-01-22 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | S - Sale+OE | $93.33 | -1,421 | 42.1K | -3% | -$132.6K |
| D | 2026-01-23 | 2026-01-21 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | M - OptEx | — | +3,334 | 43.5K | +8% | — |
| D | 2025-09-12 | 2025-09-11 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | M - OptEx | — | +18.3K | 49.5K | +59% | — |
| D | 2025-09-12 | 2025-09-12 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | S - Sale+OE | $76.01 | -9,578 | 39.9K | -19% | -$728.0K |
| D | 2025-08-12 | 2025-08-12 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | M - OptEx | $26.49 | +2,954 | 31.2K | +10% | +$78.3K |
| D | 2025-08-12 | 2025-08-11 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | S - Sale+OE | — | -8,000 | 28.2K | -22% | — |
| 2025-06-04 | 2025-06-03 | CERS | CERUS CORP | BJERKHOLT ERIC | Dir | A - Grant | $0.00 | +60.0K | 222.1K | +37% | $0 | |
| D | 2025-01-27 | 2025-01-23 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | M - OptEx | — | +2,667 | 35.9K | +8% | — |
| 2024-12-16 | 2024-12-12 | CERS | CERUS CORP | BJERKHOLT ERIC | Dir | S - Sale | $1.79 | -20.0K | 162.1K | -11% | -$35.8K | |
| 2024-11-14 | 2024-11-08 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | A - Grant | $21.05 | +475 | 33.3K | +1% | +$9,999 | |
| D | 2024-09-12 | 2024-09-11 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | M - OptEx | — | +18.3K | 32.8K | +127% | — |
| 2024-06-06 | 2024-06-05 | CERS | CERUS CORP | BJERKHOLT ERIC | Dir | A - Grant | $5.00 | +40.0K | 182.1K | +28% | +$200.0K | |
| 2024-05-16 | 2024-05-10 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | A - Grant | $21.05 | +470 | 14.5K | +3% | +$9,894 | |
| 2024-03-27 | 2024-03-27 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | P - Purchase | $24.80 | +2,000 | 14.0K | +17% | +$49.6K | |
| 2024-03-18 | 2024-03-18 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | P - Purchase | $25.80 | +2,000 | 12.0K | +20% | +$51.6K | |
| 2023-12-13 | 2023-12-13 | CERS | CERUS CORP | BJERKHOLT ERIC | Dir | P - Purchase | $1.62 | +10.0K | 142.1K | +8% | +$16.2K | |
| D | 2023-09-12 | 2023-09-11 | MIRM | Mirum Pharmaceuticals, Inc. | BJERKHOLT ERIC | CFO | P - Purchase | $29.65 | +10.0K | 10.0K | New | +$296.5K |
| 2023-08-23 | 2023-08-21 | CERS | CERUS CORP | BJERKHOLT ERIC | Dir | P - Purchase | $1.72 | +10.0K | 132.1K | +8% | +$17.2K | |
| 2023-06-09 | 2023-06-07 | CERS | CERUS CORP | BJERKHOLT ERIC | Dir | A - Grant | $5.00 | +40.0K | 122.1K | +49% | +$200.0K | |
| M | 2023-06-01 | 2023-05-30+ | CALC | CalciMedica, Inc. | BJERKHOLT ERIC | Dir | P - Purchase | $4.14 | +255 | 3,434 | +8% | +$1,055 |
| 2023-05-24 | 2023-05-23 | CALC | CalciMedica, Inc. | BJERKHOLT ERIC | Dir | P - Purchase | $3.27 | +500 | 3,429 | +17% | +$1,635 | |
| 2023-05-23 | 2023-05-23 | CERS | CERUS CORP | BJERKHOLT ERIC | Dir | P - Purchase | $2.00 | +5,000 | 82.1K | +6% | +$10.0K | |
| M | 2023-05-22 | 2023-05-18+ | CALC | CalciMedica, Inc. | BJERKHOLT ERIC | Dir | P - Purchase | $2.65 | +200 | 2,929 | +7% | +$530 |
| M | 2023-05-18 | 2023-05-16+ | CALC | CalciMedica, Inc. | BJERKHOLT ERIC | Dir | P - Purchase | $2.70 | +1,300 | 2,229 | +140% | +$3,504 |
| D | 2023-03-27 | 2023-03-23 | CALC | CalciMedica, Inc. | BJERKHOLT ERIC | Dir | D - Sale to Iss | — | +1,429 | 1,429 | New | — |
| D | 2022-06-03 | 2022-06-01 | CERS | CERUS CORP | BJERKHOLT ERIC | Dir | A - Grant | $0.00 | +20.5K | 77.1K | +36% | $0 |
Purchase Sale Sale after option exercise All abbreviations